Where does Sen-jam Pharmaceutical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sen-jam Pharmaceutical Inc. ranks #27,337 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sen-jam Pharmaceutical Inc. hold?

Sen-jam Pharmaceutical Inc. holds 10 US utility patents granted between 2019 and 2025, spanning 2 technology areas.

What is Sen-jam Pharmaceutical Inc.'s Innovation Score?

Sen-jam Pharmaceutical Inc. has an Innovation Score of 26.5 out of 100 (21st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Sen-jam Pharmaceutical Inc.'s patent grant rate increasing or decreasing?

Sen-jam Pharmaceutical Inc.'s recent grant velocity is +700% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Sen-jam Pharmaceutical Inc.'s patents?

Sen-jam Pharmaceutical Inc.'s patents average 13.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sen-jam Pharmaceutical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Sen-jam Pharmaceutical Inc.

Q: What technology areas does Sen-jam Pharmaceutical Inc. focus on?

Sen-jam Pharmaceutical Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 10 patents. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 2 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sen-jam ranks #27,337 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 2 technology areas.

#27,337
of 49,997 US assignees by volume: 21st percentile
by Innovation Score (26.5/100): 13.2
avg claims per patent: +700%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27337 · US Corporation #27,337 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,337/49,997
PHOTO-FINISH Secretary Department…
CPC-NARROW A61K · 2 areas
INNOV-THIN 26.5/100
CLAIMS-RICH 13.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +700% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Secretary, Department OF Biotechnology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Sen-jam Pharmaceutical · this assignee

27
3D Lighting… · lowest

7

What this shows Sen-jam's Innovation Score is 26.5/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Sen-jam's grants concentrate

Sen-jam Pharmaceutical Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2019. By volume, Sen-jam sits between Secretary, Department OF Biotechnology and Seoyon America Corporation.

Sen-jam's three-year grant acceleration

Sen-jam Pharmaceutical Inc. shows 4 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Secretary Departm…

10
Selas Heat Techno…

10
Semiq Incorporated

10
Semrock

10
Sensewhere

10
Sensor Internatio…

10
SEO WON Korea

10
Seoyon America

10
Sen-jam Pharmaceu… ◀

10

What this shows Sen-jam holds 10 patents at rank #27,306, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sen-jam

By rank, the assignees closest to #27,306 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Sen-jam's primary technology class.

Sen-jam's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 21st percentile higher than 21% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Sen-jam Pharmaceutical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	10.0%
2020	3	30.0%
2021	1	10.0%
2022	1	10.0%
2023	1	10.0%
2024	2	20.0%
2025partial year	1	10.0%

Which technologies does Sen-jam Pharmaceutical Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

Top 2 of 2 technology areas

Where it ranks

Overall rank by patents

#27,337

of 49,997 tracked assignees

Innovation Score

26.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Sen-jam Pharmaceutical Inc.'s patent record in context - here's where to go next.

Sen-jam Pharmaceutical Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #27,337 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sen-jam Pharmaceutical Inc. against Secretary, Department OF Biotechnology, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.